期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
新型冠状病毒肺炎患者临床分型与康复期IgG抗体衰减关系探讨 被引量:2
1
作者 谢松丽 郑雪 +1 位作者 瞿珍 许婷婷 《中国输血杂志》 CAS 2020年第8期753-754,共2页
目的通过分析武汉血液中心捐献新冠肺炎康复期血浆≥5次的7位献浆者新冠病毒IgG抗体浓度情况,探讨IgG浓度及衰减与临床分型之间的关系。方法收集献浆者患新冠肺炎期间的临床资料;患病到献浆的天数及IgG检测结果;统计分析IgG浓度、衰减... 目的通过分析武汉血液中心捐献新冠肺炎康复期血浆≥5次的7位献浆者新冠病毒IgG抗体浓度情况,探讨IgG浓度及衰减与临床分型之间的关系。方法收集献浆者患新冠肺炎期间的临床资料;患病到献浆的天数及IgG检测结果;统计分析IgG浓度、衰减与临床分型的关系。结果 7位献浆者中有4位为新冠肺炎普通型,3位为重型;抗新冠病毒IgG抗体浓度在血液中随时间逐步下降;新冠肺炎重型与普通型IgG浓度差异有统计学意义(P<0.05),IgG衰减速度差异有统计学意义(P<0.05)。结论新冠肺炎重型较普通型IgG浓度高,衰减更慢,在体内存在时间更长。 展开更多
关键词 新冠肺炎临床分型 恢复期血浆 抗体衰减
下载PDF
随机扩增DNA多态性分析用于肺炎克雷伯菌分型
2
作者 夏大平 刘敏 王丽敏 《预防医学文献信息》 1999年第2期162-162,共1页
随着抗菌素及各种免疫抑制剂的广泛应用,医院内感染日益增多。确认医院感染病原的方法有血清分型、质粒分型及限制性内切酶分型,其共同缺点是分型率低,分辨力差。我们用随机扩增DNA多态性分析(Randomly amplified polymorphic DNA analy... 随着抗菌素及各种免疫抑制剂的广泛应用,医院内感染日益增多。确认医院感染病原的方法有血清分型、质粒分型及限制性内切酶分型,其共同缺点是分型率低,分辨力差。我们用随机扩增DNA多态性分析(Randomly amplified polymorphic DNA analysis RAPD)对临床48株肺炎克雷伯菌肺炎亚种(Klebsiel-la Pneumonia subsp pneumonia kp·sp)进行分型。 1 材料与方法 菌株 1997年9月~1997年11月,本院心内科病房(19株,9人),肿瘤病房(21株,11人)及其它病房菌株(8株,7人)共48株,所有菌株经API鉴定为kp·sp。 细菌DNA制备 kp·sp纯菌落2~3个,生理盐水离心洗2次,加裂解液40μl于细菌沉淀物中,100℃10min,10000r/min离心10min,上清为PCR模板。 展开更多
关键词 多态性分析 肺炎克雷伯菌分型 DNA
下载PDF
肺炎患者抗菌药物应用情况分析
3
作者 麻铭川 《中国现代药物应用》 2009年第16期123-124,共2页
目的探讨肺炎的分型及抗菌药物治疗方法。方法不同肺炎类型抗菌药物治疗后转归情况,按疗效判断标准机型分析。结果160例肺炎抗菌治疗后临床控制95例占60.6%,显效37例占23.1%,有效19例占11.9%,无效19例占11.9%。结论肺炎治疗通常都是以... 目的探讨肺炎的分型及抗菌药物治疗方法。方法不同肺炎类型抗菌药物治疗后转归情况,按疗效判断标准机型分析。结果160例肺炎抗菌治疗后临床控制95例占60.6%,显效37例占23.1%,有效19例占11.9%,无效19例占11.9%。结论肺炎治疗通常都是以抗菌药为主,使用广谱、高效的抗菌药物,同时综合治疗重要性不能忽视。 展开更多
关键词 肺炎 肺炎分型 抗菌药物 治疗转归
下载PDF
新型冠状病毒肺炎1767例临床特征分析
4
作者 林慧艳 秦秀菊 《实用医药杂志》 2021年第6期537-539,共3页
目的探讨新型冠状病毒肺炎患者临床特征和预后。方法回顾性分析2020-02-19—2020-03-23,湖北省妇幼保健院光谷院区收治的1767例COVID-19患者的临床资料,分析临床特征与疾病分型间的关系。结果1767例患者中,轻型25例(1.41%),普通型1435例... 目的探讨新型冠状病毒肺炎患者临床特征和预后。方法回顾性分析2020-02-19—2020-03-23,湖北省妇幼保健院光谷院区收治的1767例COVID-19患者的临床资料,分析临床特征与疾病分型间的关系。结果1767例患者中,轻型25例(1.41%),普通型1435例(81.21%),重型241例(13.64%),危重型66例(3.74%)。4组间性别与年龄具有显著差异。常见症状为发热950例(53.76%),咳嗽925例(52.35%)。患者入院时的体温、心率与疾病分型无相关性,住院期间的最高体温、入院时呼吸频率与平均动脉压与疾病分型存在相关性。炎性指标与疾病分型存在相关性。该研究病死率为1.92%,主要死亡原因为呼吸衰竭,4组间的病死率差异无统计学意义。结论新型冠状病毒肺炎普通型多见,重型、危重型以高龄、男性患者发病率高,合并基础疾病多。发热、咳嗽为最常见症状。低淋巴细胞计数提示预后不良。 展开更多
关键词 新型冠状病毒 临床特征 肺炎分型 预后
下载PDF
Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection 被引量:1
5
作者 Oguzhan Okutan Zafer Kartaloglu +3 位作者 Ahmet Ilvan Ali Kutlu Erkan Bozkanat Emir Silit 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第3期381-384,共4页
AIM:To investigate pulmonary involvement via pulmonary function tests (PFT) and high-resolution computed tomocjraphy (HRCT) in patients with chronic hepatitis C virus (HCV) infection. METHODS:Thirty-four patients with... AIM:To investigate pulmonary involvement via pulmonary function tests (PFT) and high-resolution computed tomocjraphy (HRCT) in patients with chronic hepatitis C virus (HCV) infection. METHODS:Thirty-four patients with chronic HCV infection without diagnosis of any pulmonary diseases and 10 healthy cases were enrolled in the study,PFT and HRCT were performed in all cases. RESULTS:A decrease lower than 80% of the predicted value was detected in vital capacity in 9/34 patients,in forced expiratory volume in one second in 8/34 patients,and in forced expiratory flow 25-75 in 15/34 patients,respectively.Carbon monoxide diffusing capacity (DLCO) was decreased in 26/34 patients.Findings of interstitial pulmonary involvement were detected in the HRCT of 16/34 patients.Significant difference was found between controls and patients with HCV infection in findings of HRCT (X^2=4.7,P=0.003).Knodell histological activity index (KHAI) of 28/34 patients in whom liver biopsy was applied was 9.0±4.7.HRCT findings,PFT values and DLCO were not affected by KHAI in patients with HCV infection.In these patients,all the parameters were related with age. CONCLUSION:We suggest that chronic hepatitis C virus infection may cause pulmonary interstitial involvement without evident respiratory symptoms. 展开更多
关键词 Respiratory Function Tests Tomography X-Ray Computed ADULT Aged FEMALE Hepatitis C Chronic Humans Lung Diseases MALE Middle Aged
下载PDF
Novel pyrimidine-benzimidazole hybrids with antibacterial and antifungal properties and potential inhibition of SARS-CoV-2 main protease and spike glycoprotein 被引量:2
6
作者 Sharuk Khan Mayura Kale +1 位作者 Falak Siddiqui Nitin Nema 《Digital Chinese Medicine》 2021年第2期102-119,共18页
Objective The study aimed to synthesize and characterize pyrimidine-linked benzimidazole hybrids,define their antimicrobial and antifungal activities in vitro,and determine their ability to inhibit the main protease a... Objective The study aimed to synthesize and characterize pyrimidine-linked benzimidazole hybrids,define their antimicrobial and antifungal activities in vitro,and determine their ability to inhibit the main protease and spike glycoprotein of SARS-CoV-2.Methods The ability of the synthesized compounds to inhibit the main protease and spike glycoprotein inhibitory of SARS-CoV-2 was investigated by assessing their mode of binding to the allosteric site of the enzyme using molecular docking.The structures of pyrimidine-linked benzimidazole derivatives synthesized with microwave assistance were confirmed by spectral analysis.Antibacterial and antifungal activities were determined by broth dilution.Results Gram-negative bateria(Escherichia coli and Pseudomonas aeruginosa)were more sensitive than gram-positive bateria(Staphylococcus aureus and Streptococcus pyogenes)to the derivatives.Candida albicans was sensitive to the derivatives at a minimal inhibitory concentration(MIC)of 250μg/mL.The novel derivatives had better binding affinity(kcal/mol)than nelfinavir,lopinavir,ivermectin,remdesivir,and favipiravir,which are under investigation as treatment for SARS-CoV-2 infection.Compounds 2c,2e,and 2g formed four hydrogen bonds with the active cavity of the main protease.Many derivatives had good binding affinity for the RBD of the of SARS-CoV-2 spike glycoprotein with the formation of up to four hydrogen bonds.Conclusion We synthesized novel pyrimidine-linked benzi-midazole derivatives that were potent antimicrobial agents with ability to inhibit the SARS-CoV-2 spike glycoprotein.Understanding the pharmacophore features of the main protease and spike glycoprotein offers much scope for the development of more potent agents.We plan to optimize the properties of the derivatives using models in vivo and in vitro so that they will serve as more effective therapeutic options against bacterial and SARS-CoV-2 infections. 展开更多
关键词 SARS-CoV-2 inhibitor COVID-19 Molecular docking Pyrimidine-benzimidazole Bacteria Antifungal
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部